07:00 , May 4, 2015 |  BC Week In Review  |  Company News

Cellaria Biosciences, Taconic Biosciences deal

The companies partnered to improve patient-derived xenografts in animal models for oncology and immuno-oncology research. The partners will create breast cancer cell lines from Taconic’s patient-derived xenografts licensed from the University of Utah (Salt Lake...